In February 2004, the Food and Drug Administration approved the use of pemetrexed (brand name Alimta) for the treatment of malignant pleural mesothelioma asbestos. Pemetrexed is administered in combination with cisplatin mesothelioma…
More: continued here
Blogsphere: TechnoratiFeedsterBloglines
Bookmark: Del.icio.usSpurlFurlSimpyBlinkDigg
RSS feed for comments on this post | TrackBack URI for this post
Best Deal Ads :






